ArriVent

ArriVent BioPharma is a clinical-stage biopharmaceutical company focused on the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with difficult-to-treat diseases, beginning with cancers. The company operates through three strategic pillars — Discover (identifying oncology programs with strong scientific rationale), Partner & Collaborate (licensing promising candidates and building partnerships), and Develop (designing development strategies leveraging regulatory expertise). Its lead candidate is firmonertinib, an EGFR inhibitor, alongside ARR-002, a tetravalent antibody-drug conjugate. ArriVent was surfaced as a portfolio company of General Catalyst and added to the API Evangelist network. It publishes a corporate website and an investor relations site but exposes no public developer or API surface.

ArriVent is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Biopharmaceutical, Oncology, and Clinical Stage.

ArriVent’s developer surface includes support and 7 more developer resources.

🌐 Visit website 📡 Source on GitHub

14.6/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyHealthcareBiopharmaceuticalOncologyClinical StageDrug DevelopmentLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 14.6/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.9 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/arrivent: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 3

The organization behind the API

Website

Website

Careers

Careers

InvestorRelations

InvestorRelations

Other 1

Properties that don't map to a standard resource type

Pipeline

Pipeline

Source (apis.yml)

aid: arrivent
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/arrivent.png
name: ArriVent
description: ArriVent BioPharma is a clinical-stage biopharmaceutical company focused on the identification, development,
  and commercialization of differentiated medicines to address the unmet medical needs of patients with difficult-to-treat
  diseases, beginning with cancers. The company operates through three strategic pillars — Discover (identifying oncology
  programs with strong scientific rationale), Partner & Collaborate (licensing promising candidates and building partnerships),
  and Develop (designing development strategies leveraging regulatory expertise). Its lead candidate is firmonertinib, an
  EGFR inhibitor, alongside ARR-002, a tetravalent antibody-drug conjugate. ArriVent was surfaced as a portfolio company of
  General Catalyst and added to the API Evangelist network. It publishes a corporate website and an investor relations site
  but exposes no public developer or API surface.
url: https://raw.githubusercontent.com/api-evangelist/arrivent/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- general-catalyst
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Healthcare
- Biopharmaceutical
- Oncology
- Clinical Stage
- Drug Development
- Life Sciences
apis: []
common:
- type: DomainSecurity
  url: security/arrivent-domain-security.yml
- type: Website
  url: https://arrivent.com/
- type: Careers
  url: https://arrivent.com/careers/job-opportunities/
- type: Pipeline
  url: https://arrivent.com/programs/
- type: Support
  url: https://arrivent.com/contact-us/
- type: InvestorRelations
  url: https://ir.arrivent.com/
- type: TermsOfService
  url: https://arrivent.com/terms-conditions/
- type: PrivacyPolicy
  url: https://arrivent.com/privacy-policy/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence